参考文献/References:
[1] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):43-48.DOI:10.3969/j.issn.1674-7380.2010.04.013.
[2] Review Team,LaBrecque DR,Abbas Z,et al.World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J].J Clin Gastroenterol,2014,48(6):467-473.DOI:10.1097/MCG.0000000000000116.
[3] Li Z,Xue J,Chen P,et al.Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies[J].J Gastroenterol Hepatol,2014,29(1):42-51.DOI:10.1111/jgh.12428.
[4] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1): 4-67.DOI:10.3760/cma.j.issn.1674-5809.2018.01.003.
[5] Wang C,Li J,Xue H,et al.Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity[J].Diabetes Res Clin Pract,2015,107(3):424-432.DOI:10.1016/j.diabres.2014.09.059.
[6] Targher G,Valbusa F,Bonapace S,et al.Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes[J].Nutr Metab Cardiovasc Dis,2014,24(6):663-669.DOI:10.1016/j.numecd.2014.01.005.
[7] Ballestri S,Nascimbeni F,Romagnoli D,et al.Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis C virus infection--liver: the "Musketeer" in the spotlight[J].Int J Mol Sci,2016,17(3):355. DOI:10.3390/ijms17030355.
[8] Saponaro C,Gaggini M,Gastaldelli A.Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms[J].Curr Diab Rep,2015,15(6):607.DOI: 10.1007/s11892-015-0607-4.
[9] Pedersen KO. Fetuin, a new globulin isolated from serum[J].Nature,1944,154(3914):575. DOI:10.1038/154575a0.
[10] Olivier E,Soury E,Ruminy P,et al.Fetuin-B, a second member of the fetuin family in mammals[J].Biochem J,2000,350 Pt 2:589-597.
[11] Lee C,Bongcam-Rudloff E,Sollner C,et al.Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein[J].Front Biosci(Landmark Ed),2009,14:2911-2922.
[12] Kissebah AH,Sonnenberg GE,Myklebust J,et al.Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome[J].Proc Natl Acad Sci U S A,2000,97(26):14478-14483.DOI:10.1073/pnas.97.26.14478.
[13] Wilson JM,Ashton B,Triffitt JT.The interaction of a component of bone organic matrix with the mineral phase[J].Calcif Tissue Res,1977,22 Suppl:458-460.
[14] Quelch KJ,Cole WG,Melick RA. Noncollagenous proteins in normal and pathological human bone[J].Calcif Tissue Int,1984,36(5):545-549.
[15] Denecke B,Gräber S,Schäfer C,et al.Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A[J].Biochem J,2003,376(Pt 1):135-145.DOI:10.1042/BJ20030676.
[16] Wang H,Sama AE.Anti-inflammatory role of fetuin-A in injury and infection[J].Curr Mol Med,2012,12(5):625-633.
[17] Dietzel E,Wessling J,Floehr J,et al.Fetuin-B, a liver-derived plasma protein is essential for fertilization[J].Dev Cell,2013,25(1):106-112. DOI:10.1016/j.devcel.2013.03.001.
[18] Pampanini V,Inzaghi E,Germani D,et al.Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease[J].Nutr Metab Cardiovasc Dis,2018,28(1):71-76.DOI:10.1016/j.numecd.2017.09.008.
[19] Reinehr T,Roth CL.Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss[J].J Clin Endocrinol Metab,2008,93(11):4479-4485. DOI:10.1210/jc.2008-1505.
[20] Haukeland JW,Dahl TB,Yndestad A,et al.Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies[J].Eur J Endocrinol,2012,166(3):503-510.DOI:10.1530/EJE-11-0864.
[21] Meex RC,Hoy AJ,Morris A,et al.Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism[J].Cell Metab,2015,22(6):1078-1089.DOI:10.1016/j.cmet.2015.09.023.
[22] Zhu J,Wan X,Wang Y,et al.Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study[J].Endocrine,2017,56(1):208-211. DOI:10.1007/s12020-016-1112-5.
[23] Stefan N,Hennige AM,Staiger H,et al.Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fataccumulation in the liver in humans[J].Diabetes Care,2006,29(4):853-857.
[24] Mori K,Emoto M,Yokoyama H,et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabeticsubjects[J].Diabetes Care,2006,29(2):468.
[25] Kralisch S,Hoffmann A,Klöting N,et al.The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease[J].Diabetes Metab,2017,43(5):465-468.DOI:10.1016/j.diabet.2017.01.005.
[26] Luedde T,Schwabe RF.NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma[J].Nat Rev Gastroenterol Hepatol,2011,8(2):108-118.DOI:10.1038/nrgastro.2010.213.
[27] Dasgupta S,Bhattacharya S,Biswas A,et al.NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance[J].Biochem J,2010,429(3):451-462.DOI:10.1042/BJ20100330.
[28] Takata H,Ikeda Y,Suehiro T,et al. High glucose induces transactivation of the alpha2-HS glycoprotein gene through the ERK1/2 signaling pathway[J].J Atheroscler Thromb,2009,16(4):448-456.
[29] Wang D,Liu Y,Liu S,et al.Serum fetuin-B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: a cross-sectional study[J]. J Diabetes,2018,10(7):581-588.DOI:10.1111/1753-0407.12632.
[30] Ren LP,Yu X,Song GY,et al.Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells[J].Mol Med Rep,2016,14(2):1649-1658.DOI:10.3892/mmr.2016.5453.
[31] Serviddio G,Giudetti AM,Bellanti F,et al.Oxidation of hepatic carnitine palmitoyl transferase-I(CPT-I)impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet[J].PLoS One,2011,6(9):e24084.DOI:10.1371/journal.pone.0024084.
[32] Massillon D,Barzilai N,Hawkins M,et al. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion[J].Diabetes,1997,46(1):153-157.
[33] Kahraman A,Sowa JP,Schlattjan M,et al.Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients[J].Clin Sci(Lond),2013,125(8):391-400.DOI:10.1042/CS20120542.
[34] Ohashi K,Yuasa D,Shibata R,et al.Adiponectin as a target in obesity-related inflammatory state[J].Endocr Metab Immune Disord Drug Targets,2015,15(2):145-150.
[35] Hennige AM,Staiger H,Wicke C,et al.Fetuin-A induces cytokine expression and suppresses adiponectin production[J].PLoS One,2008,3(3):e1765. DOI:10.1371/journal.pone.0001765.
[36] Shi H,Kokoeva MV,Inouye K,et al.TLR4 links innate immunity and fatty acid-induced insulin resistance[J].J Clin Invest,2006,116(11):3015-3025.DOI:10.1172/JCI28898.
[37] Pal D,Dasgupta S,Kundu R,et al.Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance[J].Nat Med,2012,18(8):1279-1285.DOI:10.1038/nm.2851.
[38] Goustin AS,Derar N,Abou-Samra AB.Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor[J].Cell Signal,2013,25(4):981-988.DOI:10.1016/j.cellsig.2012.12.011.
[39] Srinivas PR,Wagner AS,Reddy LV,et al.Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level[J].Mol Endocrinol,1993,7(11):1445-1455.DOI:10.1210/mend.7.11.7906861.
[40] Mathews ST,Singh GP,Ranalletta M,et al.Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene[J].Diabetes,2002,51(8):2450-2458.
[41] Maeda N,Shimomura I,Kishida K,et al.Diet-induced insulin resistance in mice lacking adiponectin/ACRP30[J].Nat Med,2002,8(7):731-737.DOI:10.1038/nm724.
[42] Yamauchi T,Kamon J,Waki H,et al.The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7(8):941-946.DOI:10.1038/90984.
相似文献/References:
[1]曹涵,曲伸.过氧化物酶体增殖物活化受体与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2014,(06):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
Cao Han,Qu Shen..Peroxisome proliferator-activated receptors and non-alcoholic fatty liver diseases[J].International Journal of Endocrinology and Metabolism,2014,(06):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
[2]胡雅琴,包玉倩.维生素D对非酒精性脂肪性肝病的保护作用[J].国际内分泌代谢杂志,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
Hu Yaqin,Bao Yuqian..Protective effect of vitamin D on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
[3]聂秀玲,李明珍,孙丽荣.高尿酸血症与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
Nie Xiuling,Li Mingzhen,Sun Lirong..Hyperuricemia and non-alcoholic fatty liver[J].International Journal of Endocrinology and Metabolism,2016,36(06):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
[4]张洁,邸阜生.运动防治非酒精性脂肪性肝病的机制[J].国际内分泌代谢杂志,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
Zhang Jie,Di Fusheng..Mechanism of exercise on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
[5]张雅楠,郗光霞,杨翠萍,等.自噬在非酒精性脂肪性肝病中的变化及作用[J].国际内分泌代谢杂志,2017,37(01):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
Zhang Yanan*,Xi Guangxia,Yang Cuiping,et al.The change and function of autophagy in nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(06):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
[6]李博,苏青.晚期糖基化终末产物及其受体与非酒精性脂肪性肝病的
关系[J].国际内分泌代谢杂志,2017,37(03):192.[doi:10.3760/cma.j.issn.1673-4157.2017.03.013]
Li Bo,Su Qing..Relationship between advanced glycation end-products and its receptor in nonalcoholic fatty liver diseases[J].International Journal of Endocrinology and Metabolism,2017,37(06):192.[doi:10.3760/cma.j.issn.1673-4157.2017.03.013]
[7]狄红杰,刘超.饮食干预对非酒精性脂肪性肝病肠道菌群的影响[J].国际内分泌代谢杂志,2017,37(04):254.
Di Hongjie,Liu Chao..Effects of diet interventions on gut microbiota of nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(06):254.
[8]林楚曼 林伟浩 周蕊 杨力.GLP-1缓解非酒精性脂肪性肝病相关信号通路的研究进展[J].国际内分泌代谢杂志,2018,38(03):179.[doi:10.3760/cma.j.issn.1673-4157.2018.03.009]
Lin Chuman*,Lin Weihao,Zhou Rui,et al.The research progresses on GLP-1 related signal pathways in alleviating non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2018,38(06):179.[doi:10.3760/cma.j.issn.1673-4157.2018.03.009]
[9]李霞 雷涛.铁过载与代谢性疾病的关系[J].国际内分泌代谢杂志,2018,38(01):29.[doi:10.3760/cma.j.issn.1673-4157.2018.01.008]
Li Xia*,Lei Tao..Relationship between iron overload and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(06):29.[doi:10.3760/cma.j.issn.1673-4157.2018.01.008]
[10]曹白鸽 董艳.母体妊娠期高脂饮食所致的炎性反应状态对子代的影响[J].国际内分泌代谢杂志,2018,38(02):96.[doi:10.3760/cma.j.issn.1673-4157.2018.02.006]
Cao Baige*,Dong Yan..Effects of inflammatory state on offspring induced by maternal high-fat diet during pregnancy[J].International Journal of Endocrinology and Metabolism,2018,38(06):96.[doi:10.3760/cma.j.issn.1673-4157.2018.02.006]